Errors in 1H‐MRS estimates of brain metabolite concentrations caused by failing to take into account tissue‐specific signal relaxation

Accurate measurement of brain metabolite concentrations with proton magnetic resonance spectroscopy (1H‐MRS) can be problematic because of large voxels with mixed tissue composition, requiring adjustment for differing relaxation rates in each tissue if absolute concentration estimates are desired. Adjusting for tissue‐specific metabolite signal relaxation, however, also requires a knowledge of the relative concentrations of the metabolite in gray (GM) and white (WM) matter, which are not known a priori. Expressions for the estimation of the molality and molarity of brain metabolites with 1H‐MRS are extended to account for tissue‐specific relaxation of the metabolite signals and examined under different assumptions with simulated and real data. Although the modified equations have two unknowns, and hence are unsolvable explicitly, they are nonetheless useful for the estimation of the effect of tissue‐specific metabolite relaxation rates on concentration estimates under a range of assumptions and experimental parameters using simulated and real data. In simulated data using reported GM and WM T1 and T2 times for N‐acetylaspartate (NAA) at 3 T and a hypothetical GM/WM NAA ratio, errors of 6.5–7.8% in concentrations resulted when TR = 1.5 s and TE = 0.144 s, but were reduced to less than 0.5% when TR = 6 s and TE = 0.006 s. In real data obtained at TR/TE = 1.5 s/0.04 s, the difference in the results (4%) was similar to that obtained with simulated data when assuming tissue‐specific relaxation times rather than GM–WM‐averaged times. Using the expressions introduced in this article, these results can be extrapolated to any metabolite or set of assumptions regarding tissue‐specific relaxation. Furthermore, although serving to bound the problem, this work underscores the challenge of correcting for relaxation effects, given that relaxation times are generally not known and impractical to measure in most studies. To minimize such effects, the data should be acquired with pulse sequence parameters that minimize the effect of signal relaxation.

[1]  R. Bartha,et al.  Reduced hippocampal glutamate in Alzheimer disease , 2011, Neurobiology of Aging.

[2]  J. Syka,et al.  The age dependence of T2 relaxation times of N‐acetyl aspartate, creatine and choline in the human brain at 3 and 4T , 2016, NMR in biomedicine.

[3]  Muhammad G Saleh,et al.  Edited 1H magnetic resonance spectroscopy in vivo: Methods and metabolites , 2017, Magnetic resonance in medicine.

[4]  B D Ross,et al.  Absolute Quantitation of Water and Metabolites in the Human Brain. I. Compartments and Water , 1993 .

[5]  B. Mueller,et al.  Signal‐to‐noise ratio and spectral linewidth improvements between 1.5 and 7 Tesla in proton echo‐planar spectroscopic imaging , 2006, Magnetic resonance in medicine.

[6]  Mohammad Sabati,et al.  Reproducibility and reliability of short‐TE whole‐brain MR spectroscopic imaging of human brain at 3T , 2015, Magnetic resonance in medicine.

[7]  J. Frahm,et al.  Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. , 1993, Radiology.

[8]  A. Haley,et al.  Molality as a unit of measure for expressing 1H MRS brain metabolite concentrations in vivo. , 2003, Magnetic resonance imaging.

[9]  Tommaso Scarabino,et al.  Proton MR spectroscopy of the brain at 3 T: an update , 2007, European Radiology.

[10]  Christophe Ladroue,et al.  Independent component analysis for automated decomposition of in vivo magnetic resonance spectra , 2003, Magnetic resonance in medicine.

[11]  Peter Andersen,et al.  Proton T2 relaxation study of water, N‐acetylaspartate, and creatine in human brain using Hahn and Carr‐Purcell spin echoes at 4T and 7T , 2002, Magnetic resonance in medicine.

[12]  E Moser,et al.  Proton T 1 and T 2 relaxation times of human brain metabolites at 3 Tesla , 2001, NMR in biomedicine.

[13]  Jürgen R. Reichenbach,et al.  Absolute quantitation of brain metabolites with respect to heterogeneous tissue compositions in 1H-MR spectroscopic volumes , 2012, Magnetic Resonance Materials in Physics, Biology and Medicine.

[14]  Lucas C. Parra,et al.  Nonnegative matrix factorization for rapid recovery of constituent spectra in magnetic resonance chemical shift imaging of the brain , 2004, IEEE Transactions on Medical Imaging.

[15]  S. Dunham,et al.  A phase rotation scheme for achieving very short echo times with localized stimulated echo spectroscopy. , 2005, Magnetic resonance imaging.

[16]  U. Klose,et al.  Proton spectroscopy of human brain with very short echo time using high gradient amplitudes. , 1998, Magnetic resonance imaging.

[17]  Jürgen Gieseke,et al.  1H metabolite relaxation times at 3.0 tesla: Measurements of T1 and T2 values in normal brain and determination of regional differences in transverse relaxation , 2004, Journal of magnetic resonance imaging : JMRI.

[18]  R. Kreis.  Issues of spectral quality in clinical 1H‐magnetic resonance spectroscopy and a gallery of artifacts , 2004, NMR in biomedicine.

[19]  J. Nuzillard,et al.  Model-free analysis of mixtures by NMR using blind source separation , 1998, Journal of magnetic resonance.

[20]  Fawzi Boumezbeur,et al.  Metabolite and macromolecule T1 and T2 relaxation times in the rat brain in vivo at 17.2T , 2016, Magnetic resonance in medicine.

[21]  H. Neeb,et al.  Quantitative spectroscopic imaging with in situ measurements of tissue water T1, T2, and density , 2009, Magnetic resonance in medicine.

[22]  Uzay E. Emir,et al.  Faster Metabolite 1H Transverse Relaxation in the Elder Human Brain , 2013, PloS one.

[23]  V. Calhoun,et al.  Test‐retest reliability and reproducibility of short‐echo‐time spectroscopic imaging of human brain at 3T , 2011, Magnetic resonance in medicine.

[24]  Oded Gonen,et al.  Age dependence of regional proton metabolites T2 relaxation times in the human brain at 3 T , 2008, Magnetic resonance in medicine.

[25]  Terence W Nixon,et al.  High magnetic field water and metabolite proton T1 and T2 relaxation in rat brain in vivo , 2006, Magnetic resonance in medicine.

[26]  B J Soher,et al.  Quantitation of proton NMR spectra of the human brain using tissue water as an internal concentration reference , 1993, NMR in biomedicine.

[27]  Phil Lee,et al.  Imaging based magnetic resonance spectroscopy (MRS) localization for quantitative neurochemical analysis and cerebral metabolism studies. , 2017, Analytical biochemistry.

[28]  Assaf Tal,et al.  The role of gray and white matter segmentation in quantitative proton MR spectroscopic imaging , 2012, NMR in biomedicine.

[29]  Peter R Luijten,et al.  Tract‐based magnetic resonance spectroscopy of the cingulum bundles at 7 T , 2012, Human brain mapping.

[30]  O Henriksen,et al.  In vivo quantification of brain metabolites by 1H-MRS using water as an internal standard. , 1993, Magnetic resonance imaging.

[31]  Rolf Gruetter,et al.  Proton T1 relaxation times of metabolites in human occipital white and gray matter at 7 T , 2013, Magnetic resonance in medicine.

[32]  Arvind Caprihan,et al.  Use of tissue water as a concentration reference for proton spectroscopic imaging , 2006, Magnetic resonance in medicine.

[33]  Jullie W Pan,et al.  Quantitative 1H spectroscopic imaging of human brain at 4.1 T using image segmentation , 1996, Magnetic resonance in medicine.